Loading...

Intellectia LogoIntellectia
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. CLAR
CLAR logo

CLAR Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • AI Stock Picker
  • Swing Trading
  • SwingMax Portfolio
  • QuantAI Alpha Pick
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • Financial AI Agent
  • AI Screener
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Clarus Corp (CLAR) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.100
1 Day change
-2.21%
52 Week Range
4.450
Analysis Updated At
2026/03/06
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Clarus Corp (CLAR) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock shows weak financial performance, bearish technical indicators, and no significant positive catalysts. While insider buying is a positive sign, the company's declining revenue, margins, and net income, along with a lack of strong trading signals, suggest that waiting for more favorable conditions or a clearer uptrend would be prudent.

Technical Analysis

The technical indicators are bearish. The MACD is below 0 and negatively contracting, the RSI is neutral at 34.414, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading below key pivot levels, with resistance at 3.338 and support at 3.093. Overall, the stock is in a downtrend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • Insiders are buying significantly, with a 2421.42% increase in buying activity over the last month. Management has exited low-margin categories and rationalized SKUs to improve future margins.

Neutral/Negative Catalysts

  • The company reported an 8.39% YoY revenue decline in Q4 2025, a 52.29% drop in net income, and a 17.03% decline in gross margin. The stock price has been declining, and there are no recent congress trading data or significant hedge fund activity to support a bullish case.

Financial Performance

Clarus Corp's Q4 2025 financials showed a revenue decline of 8.39% YoY to $65.41 million, a net income drop of 52.29% YoY to -$31.26 million, and a gross margin decline to 27.73% from 33.4% in Q4 2024. EPS dropped to 0, down 100% YoY. The company expects 2026 sales of $255-$265 million and adjusted EBITDA of $9-$11 million, but these projections are modest given the current challenges.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have mixed views. Citi lowered the price target from $80 to $63 but maintained a Buy rating, expressing cautious optimism for 2026. Wells Fargo initiated coverage with an Equal Weight rating and a $33 price target, citing high leverage as a concern. Jefferies upgraded a related company, but this does not directly impact CLAR.

Wall Street analysts forecast CLAR stock price to rise
4 Analyst Rating
Wall Street analysts forecast CLAR stock price to rise
2 Buy
2 Hold
0 Sell
Moderate Buy
Current: 3.170
sliders
Low
3.5
Averages
4.5
High
7
Current: 3.170
sliders
Low
3.5
Averages
4.5
High
7
Citi
Buy -> Buy
downgrade
$80 -> $63
AI Analysis
2026-01-09
Reason
Citi
Price Target
$80 -> $63
AI Analysis
2026-01-09
downgrade
Buy -> Buy
Reason
Citi lowered the firm's price target on Claritev to $63 from $80 and keeps a Buy rating on the shares as part of the firm's 2026 outlook note on the health tech and distribution group. 2025 proved to be another challenging year for health tech, with nearly one-third of the group down greater than 25%, but the firm is "cautiously optimistic" looking ahead to 2026, the analyst tells investors.
Wells Fargo
Stan Berenshteyn
Equal Weight
initiated
$33
2026-01-08
Reason
Wells Fargo
Stan Berenshteyn
Price Target
$33
2026-01-08
initiated
Equal Weight
Reason
Wells Fargo analyst Stan Berenshteyn, initiated coverage of Claritev with an Equal Weight rating and $33 price target. The company is an "entrenched strategic vendor" to payers with accelerating revenue, but its elevated leverage "makes it hard to justify a premium valuation," the analyst tells investors in a research note.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CLAR
Unlock Now

People Also Watch